Literature DB >> 20509018

[Change from original preparations to generics. A case example with oxcarbazepine].

G Hagemann1, J Zinke, M Fuchs, O W Witte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20509018     DOI： 10.1007/s00115-010-3033-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  12 in total

1.  Therapeutic equivalency of generic antiepileptic drugs: results of a survey.

Authors:  Andrew N Wilner
Journal:  Epilepsy Behav       Date:  2004-12       Impact factor: 2.937

2.  Experience with generic drugs in epilepsy patients: an electronic survey of members of the German, Austrian and Swiss branches of the ILAE.

Authors:  Günter Krämer; Bernhard J Steinhoff; Martha Feucht; Margerete Pfäfflin; Theodor W May
Journal:  Epilepsia       Date:  2007-03       Impact factor: 5.864

3.  Epilepsy: Generic substitution: are antiepileptic drugs different?

Authors:  Carl W Bazil
Journal:  Nat Rev Neurol       Date:  2009-11       Impact factor: 42.937

Review 4.  The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.

Authors:  Mei Sheng Duh; Kevin E Cahill; Pierre Emmanuel Paradis; Pierre Y Cremieux; Paul E Greenberg
Journal:  Expert Opin Pharmacother       Date:  2009-10       Impact factor: 3.889

5.  Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.

Authors:  Emilio Perucca; Fiorenzo Albani; Giuseppe Capovilla; Bernardo Dalla Bernardina; Roberto Michelucci; Gaetano Zaccara
Journal:  Epilepsia       Date:  2006       Impact factor: 5.864

Review 6.  Bioequivalence of antiepileptic drugs: how close is close enough?

Authors:  Barry E Gidal
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

7.  Generic antiepileptic drugs.

Authors:  Susan J Shaw; Gregory L Krauss
Journal:  Curr Treat Options Neurol       Date:  2008-07       Impact factor: 3.598

8.  Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.

Authors:  J LeLorier; M S Duh; P E Paradis; P Lefebvre; J Weiner; R Manjunath; O Sheehy
Journal:  Neurology       Date:  2008-05-27       Impact factor: 9.910

9.  The risks and costs of multiple-generic substitution of topiramate.

Authors:  M S Duh; P E Paradis; D Latrémouille-Viau; P E Greenberg; S P Lee; M B Durkin; G J Wan; M F T Rupnow; J LeLorier
Journal:  Neurology       Date:  2009-06-16       Impact factor: 9.910

10.  Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.

Authors:  Frederick Andermann; Mei Sheng Duh; Antoine Gosselin; Pierre Emmanuel Paradis
Journal:  Epilepsia       Date:  2007-03       Impact factor: 5.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.